Clinical Trials in Salt Lake City

Showing 6801-6820 of 16,694 trials

Long-term Outcomes of Selective Dorsal Rhizotomy Among Individuals With Cerebral Palsy

NCT03789786

Spasticity affects up to 80% of individuals diagnosed with cerebral palsy. Selective dorsal rhizotomy (SDR) is a surgical method used by some hospitals to permanently reduce spasticity in order to prevent further morbidities. Better understanding of the long-term outcomes of SDR is essential for clinicians and families. The results of this study will have direct clinical impact by equipping providers with the necessary information to counsel families during medical decision making.

Cerebral Palsy

Gillette Children's Specialty Healthcare78 participantsStarted Nov 2018

Saint Paul, Minnesota, United States • Salt Lake City, Utah, United States • Spokane, Washington, United States

COMPLETEDPhase 3< 1 mile

Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)

NCT04068051

MOVEMENT (Multimechanistic Treatment over Time of Migraine Symptoms) is a Phase 3 study to evaluate the long-term safety of chronic intermittent use of AXS-07 and to assess the effect of AXS-07 on migraine symptoms following repeated treatment of migraine attacks.

Migraine

Axsome Therapeutics, Inc.706 participantsStarted Jul 2019

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Mobile, Alabama, United States +48 more locations

Long-term Outcomes of Selective Dorsal Rhizotomy Among Individuals With Cerebral Palsy

Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)

Find Trials by Condition in Salt Lake City

Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection

Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis

Neurolens Headache Study

A Study to Evaluate CBP-201, Rademikibart, in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps

A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation

Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants

TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.

Cooled Radiofrequency vs. Hyaluronic Acid to Manage Knee Pain

ANTHEM-HFrEF Pivotal Study

Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

FoxBioNet: ECV (Extracellular Vesicle) 004

In-Stent Restenosis Post-Approval Study